Jordan-based B2B healthcare marketplace Aumet, on Tuesday, announced that it has raised a six-figure pre-Series A funding round, led by Shorooq Partners.
Founded in 2016 by Yahya Aqel, Mohammad Issa, and Jamal Abu Samra, Aumet in October 2020 acquired its compatriot Uniorders.
The company claims that it has achieved an annual run-rate of $120 million worth of transactions; and in Jordan alone, currently services over 3,000 pharmacies, powering over 80 per cent of the market. It has around 50,000 manufacturers registered on its platform. Aumet has offices in Jordan, Abu Dhabi, France and has recently expanded to UAE, KSA and Egypt.
JOIN US TO STAY UPDATED ON YOUR FAVORITE MESSENGER APP!
The healthtech startup also raised $1.25 million funding in July 2020, in a round led by round led by Right Side Capital (US), TechStars, and Plug and Play.
ⓘ Interesting Read: Startup Glossary – 40+ Startup Terms Every Startup Founder & Entrepreneur Should Know
Commenting on the latest developments, Yahya Aqel, CEO of Aumetand Co-founder, in a statement, said:
“A startup’s journey will always be filled with ups and downs. What is crucial for every founder is to surround the company with partners that can support you during the downs and propel you further during the ups. With Shorooq, we have been fortunate enough to find just that.”
Mahmoud Adi, founding partner at Shorooq Partners, said,
“Last year highlighted the fragility of the global healthcare supply chain. Despite being a crucial component for our wellbeing and health, it is still deeply undigitised and as a result unorganised. We believe Aumet has phenomenal potential to solve this problem and create value on a global scale,”
ⓘ As part of our ongoing support for startups and SMEs, LAFFAZ Media publishes feature and resource articles that may include references and links to external websites. These inclusions are selected at our editorial discretion to provide valuable information to our readers. LAFFAZ Media does not control, endorse, or assume responsibility for the content or practices of external websites. For more details, please refer to our Terms and Conditions.
